Search

everythinglearnresearchcommunity

for

Search:↓

Androgens can cause hair growth in some areas and hair loss on the scalp.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Hair loss linked to higher heart disease risk in both men and women.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

p63 is essential for controlling epithelial stem cells and tissue health.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.